GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » EBITDA Margin %

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) EBITDA Margin % : 47.64% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shenzhen New Industries Biomedical Engineering Co's EBITDA for the three months ended in Mar. 2024 was ¥487 Mil. Shenzhen New Industries Biomedical Engineering Co's Revenue for the three months ended in Mar. 2024 was ¥1,021 Mil. Therefore, Shenzhen New Industries Biomedical Engineering Co's EBITDA margin for the quarter that ended in Mar. 2024 was 47.64%.


Shenzhen New Industries Biomedical Engineering Co EBITDA Margin % Historical Data

The historical data trend for Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen New Industries Biomedical Engineering Co EBITDA Margin % Chart

Shenzhen New Industries Biomedical Engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.73 52.56 48.43 53.10 52.11

Shenzhen New Industries Biomedical Engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.31 46.38 48.09 51.64 47.64

Competitive Comparison of Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin %

For the Medical Devices subindustry, Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin % falls into.



Shenzhen New Industries Biomedical Engineering Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=2047.829/3929.656
=52.11 %

Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=486.559/1021.43
=47.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen New Industries Biomedical Engineering Co  (SZSE:300832) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Shenzhen New Industries Biomedical Engineering Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Business Description

Traded in Other Exchanges
N/A
Address
No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518000
Shenzhen New Industries Biomedical Engineering Co Ltd is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. The company produces and sells series of automatic chemiluminescence immunoassay instruments and supporting reagents. Its products include Immunoassay, Clinical Chemistry, Integrated System, Lab Automation, and Reagents.
Executives
Ma Jie Supervisors
Ding Chen Liu Executives
Zhang Xiao Hong Executives
Zhang Lei Directors, executives
Li Ting Hua Executives
Liu Hai Yan Executives
Song Hong Tao Supervisors
Liu Peng Director
Jiang Li Li Supervisors

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Headlines

No Headlines